Posts Tagged ‘CLIA’

Want to increase the number of claims that successfully complete processing and enhance a positive cash flow? Heed Noridian Administrative Services’ (NAS) advice. The Medicare administrative contractor (B/MAC) has identified its top five denials for the months of July, August, and September and offers solutions and resources. Read more »

The Food and Drug Administration (FDA) recently approved a number of new tests categorized as waived complexity under the Clinical Laboratory Improvement Amendments of 1988 (CLIA).

CPT® codes for the following new tests must have the modifier QW (CLIA waived test) to be recognized as waived, with the exception of codes: 81002, 81025, 82270, 82272, 82962, 83026, 84830, 85013, and 85651.

Note: Change Request (CR) 6179 assigned 83520QW to the HemoCue Albumin 201 System. Based on a concern received from the laboratory industry, this code has been changed to 82043QW with an effective date of Oct. 1, 2009.

These new waived tests have been added to the Centers for Medicare & Medicaid Services (CMS) Medicare Claims Processing Manual, pub. 100-04, chapter 16, section 70.8.

CMS Transmittal 1799, CR 6570, issued Aug. 21, includes an attachment with an up-to-date list of tests granted waived status under CLIA.

The Food and Drug Administration (FDA) has approved new waived tests under the Clinical Laboratory Improvement Amendments (CLIA) of 1988. The latest news comes in a Centers for Medicare & Medicaid Services (CMS) transmittal issued June 5.

Read more »

The Centers for Medicare & Medicaid Services (CMS) issued Transmittal 1690, Change Request (CR) 6362, Feb. 27, to clarify a National Provider Identifier (NPI) reporting policy on claims for reference laboratory and purchased diagnostic services purchased outside the billing jurisdiction.

Read more »

New waived tests approved by the Food and Drug Administration (FDA) under the Clinical Laboratory Improvement Amendments (CLIA) of 1988 go into effect April 1.

The Centers for Medicare & Medicaid Services (CMS) released Transmittal 1689, Change Request (CR) 6370, with attachment, on Feb. 27, to inform contractors of a Recurring Update Notification (RUN) of the latest waived tests. This RUN can be found in Chapter 16, Section 70.8 of the Internet Only Manual.

To be recognized as a waived test, some CLIA waived tests have unique HCPCS Level II procedure codes and some must have modifier QW CLIA waived test included with the HCPCS Level II code. Click here to download the HCPCS Level II codes list subject to CLIA.

The Centers for Medicare & Medicaid Services (CMS) has updated the list of HCPCS codes subject to or excluded from Clinical Laboratory Improvement Amendments (CLIA) edits for 2009.

Read more »

February, American Heart Month, is a good reminder of the importance of heart health. It’s also a good time to remind health care professionals of certain Medicare benefits offered to beneficiaries for preventive care beyond the initial preventative physical examination (IPPE).

Read more »

Approximately 12,500 pathologists and cytotechnologists in the United States who screen and interpret Papanicolaou (Pap) tests to identify cervical cancers may soon be affected by a rule that alters their current requirements for cytology proficiency testing (PT).

Read more »

The Food and Drug Administration (FDA) recently approved a collection of new waived tests under the Clinical Laboratory Improvement Amendments of 1988 (CLIA). CPT® codes 83036, 81003, 82274, G0328, and 80101 must include modifier QW CLIA waived test to be recognized as a waived test.

Read more »